Image
DEEP DIVE ANALYSIS • NSE: NEWGEN • FY26 RESULTS Newgen Software Technologies Ltd: From ₹1,336 TO ₹493 — Valuation Reset or the Next Enterprise AI Compounder?  What the Q4 FY26 Numbers Actually Reveal Beneath the Midcap IT Bloodbath By SUMAN MUKHOPADHYAY | SumanSpeaks Independent Research • June 02, 2026 Newgen Software Technologies Ltd (Rs. 493)   was last trading at a pproximately ₹493 — down nearly 63% from its 52-week high near ₹1,336. In most cases, such a collapse signals severe business deterioration. But Newgen’s FY26 financials tell a far more complicated story. The company remains debt-light, highly profitable, cash-generative, and structurally positioned in one of the most important enterprise themes globally: AI-enabled workflow orchestration. Yet the stock has suffered one of the sharpest valuation compressions in the Indian en...
Tit - bits
#Sell the shares of Cadila Healthcare Ltd in the
Photo: CNN Money
F&O market at around Rs.259, for short term targets of Rs.227/220. SL: Rs.264. The scrip got charged up after this pharma major, viz Cadila Healthcare recently said that its topical manufacturing facility in Gujarat has cleared US drug regulator's inspection. It was shouted up by a number of TV men. Now it is the Bear - time for the scrip.

#Sell the shares of BPCL corresponding to the spot price of Rs. 477.80, for short term targets of Rs.441/412. SL: Rs.489. )
Investors and traders should take this, as a extreme caution, as the domestic stock markets could see a "Rolling Bear Market" that may push the S&P Nifty50 down to as much as 12/15% from the current levels; if this actually happens.

If you remember,  in my earlier write up,  I have asked all of you to lighten your buy positions; though some sporadic upward mobility, in select mid and small caps cannot be ruled out.  

Comments

Popular posts from this blog